Literature DB >> 9688069

Characterisation of the glass transition of an amorphous drug using modulated DSC.

P G Royall1, D Q Craig, C Doherty.   

Abstract

PURPOSE: The use of modulated differential scanning calorimetry (MDSC) as a novel means of characterising the glass transition of amorphous drugs has been investigated, using the protease inhibitor saquinavir as a model compound. In particular, the effects of measuring variables (temperature cycling, scanning period, heating mode) have been examined.
METHODS: Saquinavir samples of known moisture content were examined using a TA Instruments 2920 MDSC at a heating rate of 2 degrees C/min and an amplitude of +/-0.159 degrees C with a period of 30 seconds. These conditions were used to examine the effects of cycling between - 50 degrees C and 150 degrees C. A range of periods between 20 and 50 seconds were then studied. Isothermal measurements were carried out between 85 degrees C and 120 degrees C using an amplitude of +/-0.159 degrees C with a period of 30 seconds.
RESULTS: MDSC showed the glass transition of saquinavir (0.98 +/- 0.05%w/w moisture content) in isolation from the relaxation endotherm to give an apparent glass transition temperature of 107.0 degrees C +/- 0.4 degrees C. Subsequent temperature cycling gave reproducible glass transition temperatures of approximately 105 degrees C for both cooling and heating cycles. The enthalpic relaxation peak observed in the initial heating cycle had an additional contribution from a Tg "shift" effect brought about by the difference in response to the glass transition of the total and reversing heat flow signals. Isothermal studies yield a glass transition at 105.9 degrees C +/- 0.1 degrees C.
CONCLUSIONS: MDSC has been shown to be capable of separating the glass transition of saquinavir from the relaxation endotherm, thereby facilitating measurement of this parameter without the need for temperature cycling. However, the Tg "shift" effect and the number of modulations through the transition should be taken into account to avoid drawing erroneous conclusions from the experimental data. MDSC has been shown to be an effective method of characterising the glass transition of an amorphous drug, allowing the separate characterisation of the Tg and endothermic relaxation in the first heating cycle.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9688069     DOI: 10.1023/a:1011902816175

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  4 in total

Review 1.  Characteristics and significance of the amorphous state in pharmaceutical systems.

Authors:  B C Hancock; G Zografi
Journal:  J Pharm Sci       Date:  1997-01       Impact factor: 3.534

2.  Biopreservation. Putting proteins under glass.

Authors:  K C Fox
Journal:  Science       Date:  1995-03-31       Impact factor: 47.728

3.  Crystallization of indomethacin from the amorphous state below and above its glass transition temperature.

Authors:  M Yoshioka; B C Hancock; G Zografi
Journal:  J Pharm Sci       Date:  1994-12       Impact factor: 3.534

4.  Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures.

Authors:  B C Hancock; S L Shamblin; G Zografi
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

  4 in total
  9 in total

1.  Detection of low levels of the amorphous phase in crystalline pharmaceutical materials by thermally stimulated current spectrometry.

Authors:  G M Venkatesh; M E Barnett; C Owusu-Fordjour; M Galop
Journal:  Pharm Res       Date:  2001-01       Impact factor: 4.200

2.  An evaluation of the use of modulated temperature DSC as a means of assessing the relaxation behaviour of amorphous lactose.

Authors:  D Q Craig; M Barsnes; P G Royall; V L Kett
Journal:  Pharm Res       Date:  2000-06       Impact factor: 4.200

3.  Physicochemical characterization of complex drug substances: evaluation of structural similarities and differences of protamine sulfate from various sources.

Authors:  David Awotwe-Otoo; Cyrus Agarabi; David Keire; Sau Lee; Andre Raw; Lawrence Yu; Muhammad J Habib; Mansoor A Khan; Rakhi B Shah
Journal:  AAPS J       Date:  2012-06-08       Impact factor: 4.009

4.  The influence of surfactant on PLGA microsphere glass transition and water sorption: remodeling the surface morphology to attenuate the burst release.

Authors:  C Bouissou; J J Rouse; R Price; C F van der Walle
Journal:  Pharm Res       Date:  2006-05-25       Impact factor: 4.200

5.  Vertical Orientation of Liquid Crystal on Comb-Like 4-(trans-4-alkylcyclohexyl)phenoxymethyl-substituted Polystyrene Containing Liquid Crystal Precursor.

Authors:  Kyutae Seo; Hyo Kang
Journal:  Polymers (Basel)       Date:  2021-04-26       Impact factor: 4.329

6.  Synthesis and preliminary in vivo evaluations of polyurethane microstructures for transdermal drug delivery.

Authors:  Florin Borcan; Codruta M Soica; Srinivas Ganta; Mansoor M Amiji; Cristina A Dehelean; Melania F Munteanu
Journal:  Chem Cent J       Date:  2012-08-14       Impact factor: 4.215

Review 7.  Co-Amorphous Solid Dispersions for Solubility and Absorption Improvement of Drugs: Composition, Preparation, Characterization and Formulations for Oral Delivery.

Authors:  Anna Karagianni; Kyriakos Kachrimanis; Ioannis Nikolakakis
Journal:  Pharmaceutics       Date:  2018-07-19       Impact factor: 6.321

8.  Commentary: Considerations in the Measurement of Glass Transition Temperatures of Pharmaceutical Amorphous Solids.

Authors:  Ann Newman; George Zografi
Journal:  AAPS PharmSciTech       Date:  2019-12-17       Impact factor: 3.246

9.  Influence of emulsifiers on the characteristics of polyurethane structures used as drug carrier.

Authors:  Alina Heghes; Codruta M Soica; Simona Ardelean; Rita Ambrus; Danina Muntean; Atena Galuscan; Dan Dragos; Daniela Ionescu; Florin Borcan
Journal:  Chem Cent J       Date:  2013-04-10       Impact factor: 4.215

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.